For the year ending 2025-12-31, OBIO made $33,482K in revenue. -$52,955K in net income. Net profit margin of -158.16%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Total revenue | 33,482 | 2,638 | ||
| Cost of product revenues | 190 | 204 | ||
| Research and development | 58,185 | 42,804 | ||
| Selling, general and administrative | 26,914 | 23,931 | ||
| Total expenses | 85,289 | 66,939 | ||
| Loss from operations | -51,807 | -64,301 | ||
| Other expense | - | -11 | ||
| Interest (expense) income, net | -1,148 | 3,356 | ||
| Loss on fair value of strategic investments | - | -68 | ||
| Change in the fair value of derivative liability | 254 | - | ||
| Total other (expense) income | -894 | 3,277 | ||
| Net loss | -52,701 | -61,024 | ||
| Unrealized gain (loss) on marketable securities | - | 62 | ||
| Adjustment to carrying value of series a preferred stock | 254 | - | ||
| Comprehensive loss | - | -60,962 | ||
| Net loss attributable to common stockholders | -52,955 | - | ||
| Basic EPS | -1.11 | -1.66 | ||
| Diluted EPS | -1.11 | -1.66 | ||
| Basic Average Shares | 47,747,078 | 36,821,042 | ||
| Diluted Average Shares | 47,747,078 | 36,821,042 | ||
Orchestra BioMed Holdings, Inc. (OBIO)
Orchestra BioMed Holdings, Inc. (OBIO)